Amgen Corp.
AMGN Buy Stats
On December 16, 1998, the Rule Breaker portfolio bought 290 shares of rule-breaking, biotech-leading Amgen Corp. (Nasdaq: AMGN). The price paid was $85 3/4 per share before commissions. For the buy report on Amgen which explains the company in detail and why it was bought, please click here.
| ACTION: | Bought |
|---|---|
| TICKER: | AMGN |
| PRICE: | $85 3/4 |
| COMMISSION: | $8 |
| TOTAL COST: | $24,875.50 |
Why do we invest this way? Learn More
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 04/16/2024.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
